Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group
(2011) In Journal of Clinical Oncology 29(36). p.4748-4754
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/67be86dc-4fea-4b27-8e4e-1c24c5fd4e66
- author
- Nielsen, Dorte Lisbet ; Bjerre, Karsten D. ; Jakobsen, Erik H. ; Cold, Søren ; Stenbygaard, Lars ; Sørensen, Peter G. ; Kamby, Claus ; Møller, Susanne ; Levin Tykjaer Jörgensen, Charlotte LU and Andersson, Michael
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- in
- Journal of Clinical Oncology
- volume
- 29
- issue
- 36
- pages
- 4748 - 4754
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- scopus:84555218405
- ISSN
- 0732-183X
- DOI
- 10.1200/JCO.2010.33.9507
- language
- English
- LU publication?
- no
- id
- 67be86dc-4fea-4b27-8e4e-1c24c5fd4e66
- date added to LUP
- 2017-04-18 14:30:08
- date last changed
- 2025-01-07 11:29:37
@article{67be86dc-4fea-4b27-8e4e-1c24c5fd4e66,
author = {{Nielsen, Dorte Lisbet and Bjerre, Karsten D. and Jakobsen, Erik H. and Cold, Søren and Stenbygaard, Lars and Sørensen, Peter G. and Kamby, Claus and Møller, Susanne and Levin Tykjaer Jörgensen, Charlotte and Andersson, Michael}},
issn = {{0732-183X}},
language = {{eng}},
number = {{36}},
pages = {{4748--4754}},
publisher = {{Lippincott Williams & Wilkins}},
series = {{Journal of Clinical Oncology}},
title = {{Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group}},
url = {{http://dx.doi.org/10.1200/JCO.2010.33.9507}},
doi = {{10.1200/JCO.2010.33.9507}},
volume = {{29}},
year = {{2011}},
}